ASH 2021: Meet Valarie Traynham - Personalized Medicine for a Personal Disease

MYELOMA NEWS - December 04, 2021

Fostering community and change are essential parts of Valarie Traynham’s DNA.  After her diagnosis she started attending a local support group and so... Read More

ASH 2021: Myeloma Crowd by HealthTree Has ASH Covered

The annual American Society of Hematology (ASH) meeting is the most important important meeting of the year for medical professionals working in myeloma.  ... Read More

HealthTree University: Myeloma Genetics (1/3)

As we learn more about multiple myeloma, we are understanding how myeloma genetics affect your risk level, how the genetics of the disease change over time, and... Read More

Join Us Live or Online for the Miami MCRT on January 22

UPCOMING MC ROUND TABLES - December 02, 2021

Get away from the winter doldrums in sunny Florida for the first-ever Myeloma Crowd Round Table in Miami, Florida on Saturday, January 22, 2022 at the Hilton Av... Read More

How the Build Back Better America Bill Addresses the Costs of Medicines & Care for Medicare Beneficiaries

LIFE WITH MYELOMA - December 02, 2021

The Build Back America Bill that has been on everyone's lips is now headed to the Senate where it still faces a battle for approval. But what is all the tal... Read More

Small Changes Make the Biggest Impact

MUSCLES FOR MYELOMA - December 01, 2021

This week we are focusing on how small changes can make the biggest impact. Our goal at the HealthTree Foundation is to change the way Multiple Myeloma is treat... Read More

Darzalex FASPRO Gets FDA Approval for Use With Carfilzomib and Dexamethasone

MYELOMA NEWS - December 01, 2021

Darzalex FASPRO (the subcutaneous shot of daratumumab) has received its ninth FDA approval, this time with use in combination with carfilzomib and dexamethasone... Read More

Help Us Make Change in Myeloma Research Today on #GivingTuesday

LIFE WITH MYELOMA - November 30, 2021

Help us make Change in Multiple Myeloma Research Today on #GivingTuesday Please help us reach our matching grant of $200,000 for a total fundraise of $400,00... Read More

One Patient’s Motivation: BBC Profiles Jenny Ahlstrom

LIFE WITH MYELOMA - November 28, 2021

“It took me eight years to get up to speed on myeloma, and that’s not fair for other patients.”            ... Read More

Tips and Tools to Manage Loneliness During the Holidays

MYELOMA COACH - November 27, 2021

This time of year brings hustle, bustle, food, and family gatherings. For some, it is a joyful, full time and for others a time of loneliness. Whether... Read More

HealthTree University: Specific Myeloma Genetics Mutations and Risk (3/3)

HEALTHTREE - November 27, 2021

Did you know that the genetics of your myeloma affect how high-risk or low-risk your disease is? Some of the top myeloma doctors in the world answered our quest... Read More

Giving Tuesday - The History

MCRI - November 26, 2021

This November 30th, we will be celebrating Giving Tuesday. On this global day of giving, the Myeloma Crowd by HealthTree is working to raise $400,000 to make re... Read More

A Potential Warning Sign for Allo CAR T in Multiple Myeloma

MYELOMA NEWS - November 24, 2021

Myeloma Crowd by HealthTree has posted several articles recently here and here about the potential of donor CAR-T cell therapy. These CAR-T cells have the ... Read More

Find Myeloma Help

Myeloma Financial Resource


Find financial resources like housing, prescription and patient assistance programs and other helpful links that will guide you through your myeloma care.

Myeloma Specialist


Patients who are seen by myeloma specialists live longer. Find a myeloma specialists closest to you and add them to your care team for your best outcomes.

Myeloma Clinical Trials


Find personally relevant treatment options and clinical trials at every stage of your myeloma with HealthTree and SparkCures.

Myeloma Coach


We're a team of myeloma patient and caregiver volunteers who can help you find and use the best myeloma resources so you can better navigate your myeloma care.

Thanks to our Myeloma Crowd Community sponsors:

.                         .       .